Mirum Pharmaceuticals Inc
General ticker "MIRM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.1B
Mirum Pharmaceuticals Inc follows the US Stock Market performance with the rate: 52.0%.
Estimated limits based on current volatility of 1.6%: low 41.16$, high 42.52$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [21.91$, 43.56$]
- 2024-12-30 to 2025-12-30 estimated range: [23.55$, 45.88$]
Financial Metrics affecting the MIRM estimates:
- Negative: Non-GAAP EPS, $ of -2.95 <= 0.10
- Negative: Operating profit margin, % of -36.94 <= 1.03
- Negative: Operating cash flow per share per price, % of -5.14 <= 2.35
- Negative: negative Net income
- Positive: -3.48 < Investing cash flow per share, $ of -2.62
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term MIRM quotes
Long-term MIRM plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $19.14MM | $77.06MM | $186.37MM |
| Operating Expenses | $192.55MM | $208.28MM | $295.53MM |
| Operating Income | $-173.41MM | $-131.22MM | $-109.15MM |
| Non-Operating Income | $89.46MM | $-10.85MM | $-53.27MM |
| Interest Expense | $17.59MM | $15.98MM | $15.11MM |
| R&D Expense | $131.43MM | $106.84MM | $102.61MM |
| Income(Loss) | $-83.95MM | $-142.07MM | $-162.42MM |
| Taxes | $0.04MM | $-6.41MM | $0.99MM |
| Profit(Loss) | $-83.99MM | $-135.66MM | $-163.41MM |
| Stockholders Equity | $120.21MM | $142.04MM | $248.67MM |
| Inventory | $1.51MM | $5.57MM | $22.31MM |
| Assets | $294.65MM | $352.91MM | $646.62MM |
| Operating Cash Flow | $-132.76MM | $-120.14MM | $-70.94MM |
| Capital expenditure | $19.02MM | $0.28MM | $20.11MM |
| Investing Cash Flow | $48.55MM | $7.70MM | $-107.20MM |
| Financing Cash Flow | $73.47MM | $109.09MM | $336.60MM |
| Earnings Per Share* | $-2.77 | $-4.01 | $-4.00 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.